Welcome to our dedicated page for Aimei Health Technology Co SEC filings (Ticker: AFJK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aimei Health Technology Co., Ltd. filings document the regulatory record of a Cayman Islands blank-check company with ordinary shares, units and rights registered for Nasdaq trading. The filings describe SPAC mechanics such as trust-account funding, redemption-related timelines, deadline extensions, shareholder voting procedures and amendments to governing documents.
Recent 8-K, proxy and late-filing records also disclose direct financial obligations, unsecured promissory notes used to fund extension payments, capital-structure terms, material agreements, Nasdaq listing-compliance notices, delayed annual-report reporting and governance matters associated with the company's initial business-combination process.
Aimei Health Technology Co., Ltd extended the deadline to complete its initial business combination by one month, moving the termination date from October 6, 2025 to November 6, 2025. To fund this extension, an aggregate $150,000 was deposited into the company’s trust account for public shareholders.
The company issued a $150,000 unsecured promissory note dated October 8, 2025 to its sponsor, Aimei Health Ltd, and United Hydrogen Group Inc., with each contributing $75,000. The note bears no interest and becomes payable when Aimei completes its business combination with United Hydrogen. The payees may choose to convert the note into private units at $10.00 per unit, with each unit consisting of one ordinary share and a right to receive one-fifth of one ordinary share, immediately prior to closing the business combination.